Becker's Healthcare September 20, 2024
Alexandra Murphy

As the demand for GLP-1 drugs grows, there are several factors emerging that could result in its price decreasing.

Here are five reasons Ozempic prices could drop:

  1. Ozempic, manufactured by Novo Nordisk, could be part of upcoming drug price negotiations with CMS If it is included, it might face price reductions as the government pushes for lower costs on high-demand medications such as GLP-1 drugs.
  2. Competitors such as Eli Lilly have already started offering discounts on their GLP-1 drugs to expand their market share, The Wall Street Journal reported Sept. 20.
  3. Sen. Bernie Sanders has advocated for the introduction of generic versions...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Pharma / Biotech
Related Articles:
Trump tariffs could drive up generic drug costs: 5 takeaways
Answer ALS, Cedars-Sinai Collaboration, Single-Cell Protein Profiling, ChapsVision Acquires Sinequa, More
Pharma Pulse 11/25/24: Deepening Patient Relationships,
Halozyme abandons its €2bn pursuit of Evotec
BridgeBio poised to challenge Pfizer after Attruby approval

Share This Article